Logotipo Fundación Kovacs
  Home   Español   Glossary   Map   Contact   The web of the back   Back Pain Research Network
 The Foundation Medical Research Health Care Promoting Public Health
  Objective and general criteria
  Priority fields of investigation
  Research projects on back disorders
  Research Projects on the System of K-Channels
  Other Lines of Research

Medical Research>> Research projects on back disorders>> Projects on clinical practice>> Homologation of the criteria for the diagnosis and treatment of back disorders in Europe

  Projects on risk factors
  Projects on aspects of assessment, diagnosis and prognosis
  Projects on treatments
  Projects on clinical practice
  - Variability of Clinical Practice regarding Back Pain in Spain
  - The efficiency of treatment for back pain in Spain
  - Homologation of the criteria for the diagnosis and treatment of back disorders in Europe

  HOMOLOGATION OF THE CRITERIA FOR THE DIAGNOSIS AND TREATMENT OF BACK DISORDERS IN EUROPE

Title.

Management of non-specific low back pain based on scientific evidence.

Background.

Back disorders ("mechanical pathologies of the spine") represent a major problem for industrialized countries, both because of their frequency and because of their health care and labor costs. Physicians tend not to bear in mind the results of scientific studies when deciding on the recommendations to make to their patients with back pain. This means that a large number of patients are being subjected to inappropriate diagnostic procedures or treatments, or at least those not indicated in their case. Furthermore, it means that the health care cost that these patients generate is greater than necessary. This problem affects most European countries alike.

Objective.

To prepare a Guideline for Clinical Practice on Non-Specific Low Back Pain, based on scientific evidence and in a Pan-European setting. With this end:

  1. To analyze the available scientific evidence on the usefulness and criteria for recommendation of each one of the available diagnostic procedures and treatments for back pain.

  2. To identify the procedures which have not been evaluated with sufficient methodological quality, and thus to define the priority areas of research.

  3. To bring together procedures (diagnostic and therapeutic) on whose utility scientific evidence exists, establishing a Guideline for Clinical Practice that encourages performance standards based on those recommended by the available scientific evidence in order to ensure the greatest efficacy (relation cost/outcome) of health resources.

  4. To distribute and recommend the use of this protocol among physicians, especially those in Primary Care.

Methodology.

With the goal of preparing the Guideline for Clinical Practice, a Pan-European program was put into effect through the COST organization of the European Commission. A "Managing Committee" was constituted, made up of the leading European researchers and clinics in the field of back disorders. Due to COST's work system, the experts forming part of the Committee had to be named by the national governments of each one of the countries participating in the program. And among them, the majority had participated in the creation of the clinical guidelines based on scientific evidence that already exist in the different European countries.

The Managing Committee formed three work groups centered, respectively, on defining the recommendations referring to the prevention of pain, acute pain and chronic pain. Each one of these Work Groups was made up of members of the Managing Committee and by other experts specialized in the specific subject, who were selected for the importance of their scientific work in the corresponding field.

Each Work Group was in Charge of:

  1. Analyzing the available scientific evidence on each one of the relevant procedures for its area (prevention or diagnosis and treatment of acute or chronic low back pain). However, as several clinical Guidelines on acute low back pain already exist (based on existing scientific evidence), the corresponding Work Group did not repeat the evaluation of the scientific evidence already reviewed but rather used the already existing Guidelines as a point of departure.

  2. Approving a recommendation based on the available scientific evidence on the use or avoidance of each procedure.

  3. Combining the recommended diagnostic and therapeutic procedures, defining a protocol for behavior that ensures the greatest efficacy and efficiency (cost/outcome) possible of the available resources.

Furthermore, a Spanish Work Group was formed, with specialists named by the medical societies representing physicians involved in handling patients with back disorders (primary care physicians, radiologists, rehabilitation specialists, rheumatologists, traumatologists, neurosurgeons, specialists in occupational medicine, etc.). This Group's missions were: to transmit the scientific studies published in Spanish which the Managing Committee may have overlooked, to comment on the drafts of the Guidelines and to collaborate in its distribution and promoting its application.

In order to avoid needless repetition, the COST B13 program bears in mind the previous work done by other groups, such as the Cochrane Collaboration, the Agency for Health Care Policy and Research (USA), the Royal College of General Practitioners (United Kingdom) and the Swedish Agency for the Evaluation of Health Care Technologies (Sweden- SBU).

However, most of these groups have formulated their recommendations on the basis of scientific studies published in English only. Furthermore, the political and economic pressures that certain professional groups have exercised in some countries have resulted in contradictory recommendations formulated by different groups on the basis of the same evidence. Additionally, all of these Guidelines have been centered on handling patients with acute ailments, but nearly none has provided recommendations on prevention or for the treatment of chronic patients, who generate more than 80% of the global costs derived from back problems.

For that reason, the B13 Management Committee brought the scientific foundations on which these recommendations are based up-to-date and incorporated the reliable scientific studies published in other languages (the Spanish Work Group helped to identify 16 studies published in Spanish that had been ignored by previous Guidelines for Clinical Practice). It included scientific evidence referring to chronic cases and to mechanisms of prevention in order to provide more complete information. Also, as a Pan-European venture, it was better prepared to resist the pressures that some professional groups might exercise on a local or national level.

Participants, along with the Foundation's Science Department.

The main experts in mechanical pathologies of the spine of the different European countries who participate as members of the Managing Committee and/or the Work Groups. In all, there are 49 experts from Austria, Belgium, Denmark, Finland, France, Germany, Holland, Italy, Israel, Norway, Spain, Sweden, Switzerland, and the United Kingdom.

Additionally, in the Spanish Work Group, there are 14 experts from 10 Spanish Scientific societies representative of their disciplines, relevant to the diagnosis and treatment of back disorders.

The Spanish portion is funded entirely by the Kovacs Foundation. The COST organization, under the European Commission's Secretariat for Research is responsible for funding the international coordination.

Status.

This project was begun in October 1999. The preparation of the guidelines for clinical practice is in progress.

subir subir
© Fundación Kovacs 2005